Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 262-967-7 | CAS number: 61788-32-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-compliant study, available as unpublished report, no restrictions, adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
- Objective of study:
- distribution
- Principles of method if other than guideline:
- Other: Monsanto Company internal method.
Study conducted in general accordance with GLP Standards with the following exceptions:
- The stability of the test substance, neat and after mixing with carrier, was not determined; however stability can be inferred from Benzene, mono-C10-13-alkyl derivs., distn. residues studies.
- Characterization of the test substance was not conducted according to the standards.
- Characterization and stability data for reference substances were not developed according to the standards.
These deviations should not impact the interpretation of the study. - GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Terphenyl, hydrogenated
- EC Number:
- 262-967-7
- EC Name:
- Terphenyl, hydrogenated
- Cas Number:
- 61788-32-7
- Molecular formula:
- C18Hn (n >18-36)
- IUPAC Name:
- Terphenyl, hydrogenated
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories (Portage, MI)
- Age at study initiation: approximately seven to ten weeks of age
- Weight at study initiation: 200-350 gm
- Housing: one per cage
- Diet (e.g. ad libitum): ad libitum (Purina Certified (#5002) Laboratory Rodent Chow )
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least ten days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 72+2 °F
- Humidity (%): 35-60%
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Rats were gavaged using a 2 mL syringe fitted with a straight Perfectum 16 or 18 gauge, 2-inch animal feeding needle (Popper and Sons, inc., New Hyde Park, NY). The dose was contained in approximately 1.1-1.6 mL of solution.
VEHICLE
- Concentration in vehicle: 65.2 mg/g
- Duration and frequency of treatment / exposure:
- single dose
Doses / concentrations
- Dose / conc.:
- 300 mg/kg bw/day
- No. of animals per sex per dose / concentration:
- Nine male rats per dose level
- Control animals:
- not specified
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled: urine, faeces, blood, liver, kidney, intestinal contents and carcasses
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Absorption was not determined in this study. However, the minimum amount absorbed, calculated as the amount of radioactivity excreted in the urine plus the amount of radioactivity in the organs and carcass, was approximately 31.9% (normalized data) of the administered dose 8 hours after gavage.
- Details on distribution in tissues:
- The gut contents, followed by the carcass and liver, contained the majority of hydrogenated terphenyl derived radioactivity 8 hours after administration. Within 48 hours the radioactivity in the gut contents had declined by a factor of 10, while the radioactivity in the feces had increased, suggesting that most of the material in the feces was composed of unabsorbed parent compound.
Based on a per gram concentration basis, greater than 1% of the dose/per gram of gastrointestinal contents was detected in the gut 8 hours after gavage. Although almost ten times more material was observed in the carcass compared to the liver there was little difference when the % dose was expressed as per gram of tissue (0.22 and 0.37% administered dose/gram, respectively, liver and carcass). The large proportion of dose in the carcass was due to its larger mass compared to the liver.
- Details on excretion:
- The greatest amount of radioactivity was found in the intestinal contents 8 hours after an oral dose of hydrogenated terphenyl at 300 mg/kg, with the faces representing the major route of elimination. After 48 hours the amount detected in the feces had increased to approximately 75% of the administered dose and at 168 hours greater than 85% of the dose had been excreted by fecal elimination. Approximately 11 % of the administered dose was excreted in the urine over the 168 hour observation period.
Elimination of hydrogenated terphenyl derived radioactivity best fit a 1 compartment model. The half-lives for elimination via the urine and feces were estimated to be 23.0 and 13.0 hours, respectively. The whole body elimination reflected that of the feces and the half-life was estimated to be 14.0 hours.
Any other information on results incl. tables
Liver and kidney weights liver weights were significantly increased above control liver weights only in animals administered 300 mg/kg of hydrogenated terphenyl.
The test material was not readily absorbed and did not appear to accumulate in rat body tissues following a single gavage dose of 300 mg/kg. Very little radiolabel was evident in the kidney and liver 48 hours after gavage. Generally the test material appeared to have little effect on AHH or ECOD activity following single exposure, although some statistically significant changes in enzymatic activity were noted.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: no bioaccumulation potential based on study results
Hydrogenated terphenyl was not readily absorbed and did not appear to accumulate in body tissues following a single gavage of 300 mglkg. The fecal half-life was about 13 hours and the urinary half-life was about 23 hours. The whole body half-life was estimated to be about 14 hours and the primary route of elimination was via the feces. Very little radiolabel was evident in the kidney and liver 48 hours after gavage and little enzyrne induction was noted in these tissues. - Executive summary:
Hydrogenated terphenyl was not readily absorbed and did not appear to accumulate in body tissues following a single gavage of 300 mg/kg in male rats. The fecal half-life was about 13 hours and the urinary half-life was about 23 hours. The whole body half-life was estimated to be about 14 hours and the primary route of elimination was via the feces. Very little radiolabel was evident in the kidney and liver 48 hours after gavage and little enzyrne induction was noted in these tissues.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.